What is new?

Read all news items about the AGE Reader, Diab-spot and DiagnOptics.

Diagnoptics appoints DiosPharma as the new Korean distributor

Groningen, the Netherlands – November 7, 2016

Diagnoptics is glad to announce, that DiosPharma has been appointed as the new distributor of the AGE Reader mu in Korea. DiosPharma will be responsible for the marketing & sales as well as the regulatory approval of the AGE Reader mu in Korea. “After recently starting successful partnerships in Japan and China, this distribution agreement means another step into a major market in Asia for Diagnoptics” said Diagnoptics’ CEO Bart van den Berg.

DiosPharma will start with obtaining regulatory approval from the Korean MFDS (Ministry of Food and Drug Safety) for the AGE Reader mu. This process is expected to take 10-12 months after which DiosPharma will offer the AGE Reader mu to the Korean market.

DiosPharma Co., Ltd. is dedicated to medical device and pharmaceuticals industry since its foundation in 2008. Tim Souk, CEO of DiosPharma: “We have overcome many challenges while continuing to grow and contribute to the advancement of Korean market. We have been dedicating innovative product to medical device as non-invasive products as well as in & out licensing of generic pharmaceuticals. In order for human health to become a leader, DiosPharma will strive to lead continuous improvement through ongoing research and development and innovative solutions for healthcare.”

Distributor details DiosPharma

Share this link on:

Latest news items

  1. Diagnoptics appoints DiosPharma as the new Korean distributor 2016
  2. Visit Diagnoptics at the EASD congress 2016 in Munich 2016
  3. Selista appointed as new Japanese distributor for the AGE Reader mu 2016
  4. Diagnoptics bei dem DDG Kongress in Berlin 2016
  5. Diagnoptics receives Chinese market approval for AGE Reader SU 2016
  6. New patent granted to Diagnoptics in Japan and EU. 2016
  7. Diagnoptics receives Japanese market approval for AGE Reader mu. 2015
  8. Diagnoptics nominated for Deloitte Technology Fast50 2015
  9. Scientific review emphasises need for AGE measurements and interventions 2015
  10. Dutch government supports Diagnoptics and CTMM research project 2015
  11. Key publication: AGE Reader predicts amputation 2015
  12. New AGE Reader video available: quick start guide and user instructions. 2015
  13. Diagnoptics appoints Forel Medical as new Polish distributor 2015
  14. Diagnoptics appoints Microcaya as new Spanish distributor 2015
  15. Diagnoptics appoints ANL Produkter AB as new Swedish distributor 2015
  16. Exciting video: AGE Reader clinical case study 2014
  17. Review about AGE Reader in assessing CV risk and risk of diabetes 2014
  18. Excellent presentation about Advanced Glycation Endproducts (Dutch) 2014
  19. Editorial confirms added value of AGE Reader in atherosclerosis 2014
  20. Breakthrough publication: AGE Reader in atherosclerosis 2014
  21. German review AGE Reader 2014
  22. Upcoming Conferences 2014
  23. DiagnOptics moved to another location. 2014
  24. AGE Reader on national television 2013
  25. A.J. Smit appointed professor at the UMCG 2013
  26. Visit DiagnOptics at the EASD 2013 2013
  27. Clinical validation Diab-spot published 2013
  28. DiagnOptics receives CE mark approval for AGE Reader mu 2013
  29. DiagnOptics to show new product at international diabetes meetings in 2013 2012
  30. AGE Reader presented at German national diabetes conference in Berlin. 2012
  31. Successful introduction of the AGE Reader mu 2012
  32. Important role of AGE Reader shown in recent international publications 2012
  33. DiagnOptics present at the EASD 2012 in Berlin 2012
  34. DiagnOptics receives Health Canada approval for Diab-spot 2012
  35. DiagnOptics and PATH partner on project on diabetes screening in India 2012
  36. DiagnOptics receives CE mark approval for Diab-spot. 2011
  37. DiagnOptics receives Health Canada approval for the AGE Reader. 2011
  38. New product for diabetes detection, Diab-spot, introduced in Madrid. 2011
  39. DiagnOptics receives ISO 13485 certification. 2010
More Information
Request information

Would you like to learn more about our products? Request any information you wish to receive here.

AGE Reader mu
Non-invasive cardiovascular risk assessment
Age Reader MU
The AGE Reader mu is the next generation AGE Reader that combines a high measurement quality standard with an innovative design, at a reduced pricelevel. The AGE Reader mu is a perfect tool for diabetologists and family doctors.

Read more »
Newsletter subscription

If you want to receive the newsletter with information about DiagnOptics' products, please send us your email address.


Downloads about the AGE Reader and Diab-spot

About the company

Find information about Diagnoptics.

Information for patients

Find information about Diagnoptics' products and Advanced Glycation Endproducts.

Information for professionals

Find information about Advanced Glycation Endproducts, the AGE measurement and the clinical validation.